SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Courtney, P A
Right arrow Articles by Bell, A L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Courtney, P A
Right arrow Articles by Bell, A L
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity

P A Courtney

Department of Rheumatology and Immunology, Royal Victoria Hospital, Belfast; Department of Rheumatology and Immunology, Musgrove Park Hospital, Stockman's Lane, Belfast, BT0 7JB, Ireland

A D Crockard

Department of Rheumatology and Immunology, Royal Victoria Hospital, Belfast; Arthritis Research Group, Centre for Inflammation and Repair, Musgrave Park Hospital, Belfast

K Williamson

Arthritis Research Group, Centre for Inflammation and Repair, Musgrave Park Hospital, Belfast

J McConnell

Department of Rheumatology and Immunology, Royal Victoria Hospital, Belfast

R J Kennedy

Arthritis Research Group, Centre for Inflammation and Repair, Musgrave Park Hospital, Belfast

A L Bell

Department of Rheumatology and Immunology, Royal Victoria Hospital, Belfast; Arthritis Research Group, Centre for Inflammation and Repair, Musgrave Park Hospital, Belfast

Lupus specific autoantigens are exposed on apoptotic cells. The increased number of apoptotic lymphocytes reported in systemic lupus erythematosus (SLE) may be attributable to abnormalities of lymphocyte Fas expression or serum soluble Fas.

In the present study we analysed the count of circulating apoptotic lymphocytes in SLE patients (n ‘ 50), by flow cytometry using Annexin V, compared to rheumatoid arthritis patients (RA, n ‘ 20), inflammatory bowel disease patients (IBD, n ‘ 20) and normal controls (n ‘ 20). Lymphocyte Fas expression and serum soluble Fas were measured and related to numbers of apoptotic lymphocytes.

The percentage of apoptotic lymphocytes, determined by Annexin V binding, was significantly increased in peripheral blood of SLE patients (median ‘ 4.2%) compared with normal healthy donors (median ‘ 1.1%) and IBD patients (median ‘ 2.0%) but not RA (median ‘ 3.9%). SLE lymphocyte Fas expression was not significantly different from RA or IBD patients. Serum soluble Fas in SLE patients correlated positively with apoptotic lymphocytes and antibodies to double stranded DNA.

This study suggests that increased apoptotic lymphocytes and increased lymphocyte Fas expression may not be specific to SLE. Serum soluble Fas may have a role in the regulation of lymphocyte apoptosis in SLE.

Key Words: SLE • lymphocyte • apoptosis • Fas • soluble Fas

Lupus, Vol. 8, No. 7, 508-513 (1999)
DOI: 10.1191/096120399678840765


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
M. Lim, D. Sheen, S. Kim, S. Won, S-S Lee, S-C Chae, H-T Chung, and S. Shim
IAN5 polymorphisms are associated with systemic lupus erythematosus
Lupus, October 1, 2009; 18(12): 1045 - 1052.
[Abstract] [PDF]


Home page
LupusHome page
V Dhir, A. Singh, A Aggarwal, S Naik, and R Misra
Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study
Lupus, August 1, 2009; 18(9): 785 - 791.
[Abstract] [PDF]


Home page
Int ImmunolHome page
E. Tinazzi, A. Puccetti, R. Gerli, A. Rigo, P. Migliorini, S. Simeoni, R. Beri, M. Dolcino, N. Martinelli, R. Corrocher, et al.
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment
Int. Immunol., March 1, 2009; 21(3): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
P. E Westerweel, R. K M A C Luijten, I. E Hoefer, H. A Koomans, R. H W M Derksen, and M. C Verhaar
Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus
Ann Rheum Dis, July 1, 2007; 66(7): 865 - 870.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C-H. Wu, S-C. Hsieh, K-J. Li, M-C. Lu, and C-L. Yu
Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity
Lupus, April 1, 2007; 16(4): 265 - 272.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
D J Armstrong, A D Crockard, E M Whitehead, and A L Bell
Anti-C1q antibodies in renal and non-renal SLE
Ann Rheum Dis, July 1, 2005; 64(7): 1108 - 1108.
[Full Text] [PDF]


Home page
LupusHome page
C Kayser, F L Alberto, N P da Silva, and L E. Andrade
Decreased number of T cells bearing TCR rearrangement excision circles (TREC) in active recent onset systemic lupus erythematosus
Lupus, December 1, 2004; 13(12): 906 - 911.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
J. D. Johnson, K. L. Hess, and J. M. Cook-Mills
CD44, {alpha}4 integrin, and fucoidin receptor-mediated phagocytosis of apoptotic leukocytes
J. Leukoc. Biol., November 1, 2003; 74(5): 810 - 820.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E Smolewska, H Brozik, P Smolewski, M Biernacka-Zielinska, Z Darzynkiewicz, and J Stanczyk
Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis
Ann Rheum Dis, August 1, 2003; 62(8): 761 - 763.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C C Mok and C S Lau
Pathogenesis of systemic lupus erythematosus
J. Clin. Pathol., July 1, 2003; 56(7): 481 - 490.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
F Silvestris, D Grinello, M Tucci, P Cafforio, and F Dammacco
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus
Lupus, January 1, 2003; 12(1): 8 - 14.
[Abstract] [PDF]


Home page
LupusHome page
G Grondal, K H Traustadottir, H Kristjansdottir, I Lundberg, L Klareskog, K Erlendsson, and K Steinsson
Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families
Lupus, July 1, 2002; 11(7): 435 - 442.
[Abstract] [PDF]


Home page
LupusHome page
M Bijl, G Horst, P C Limburg, and C G. Kallenberg
Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity
Lupus, December 1, 2001; 10(12): 866 - 872.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
A P Cairns, A D Crockard, J R McConnell, P A Courtney, and A L Bell
Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity
Ann Rheum Dis, October 1, 2001; 60(10): 950 - 955.
[Abstract] [Full Text] [PDF]



Advertisement